openPR Logo
Press release

CAR-T Cell Therapy Competitive Landscape 2024 (Updated)

10-27-2024 12:22 PM CET | Health & Medicine

Press release from: DelveInsight

CAR-T Cell Therapy Market

CAR-T Cell Therapy Market

DelveInsight's, "CAR T Cell Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the CAR-T Cell Therapy Report
• DelveInsight's CAR-T Cell Therapy report depicts a robust space with 250+ active players working to develop 500+ pipeline therapies for CAR-T Cell Therapy treatment.
• The leading companies working in the CAR-T Cell Therapy Market include Cartesian Therapeutics, CASI Pharmaceuticals, Juventas Cell Therapy, Novartis, Poseida Therapeutics, Shanghai Unicar-Therapy Bio-medicine Technology, JW Therapeutics, Gilead Sciences, Cellular Biomedicine Group, Gracell Bio, Mustang Bio, Servier, iCell Gene Therapeutics, Kecellitics Biotech Company Ltd, Gilead sciences, Miltenyi Biotech, Nanjing KAEDI Biotech, Liminatus Pharma, Yake Biotechnology, AffyImmune Therapeutics, Fundamenta Therapeutics, Actinium Pharmaceuticals, Allogene Therapeutics, Celyad Oncology, Maxcyte, Sorrento Therapeutics, Cellular Biomedicine Group, Sorrento Therapeutics, Shanghai GeneChem Co., Ltd., Sensei Biotherapeutics, Obsidian Therapeutics, Beijing Biohealthcare Biotechnology Co. Ltd. , Eutilex/Utilities, Precigen, Inc., Miltenyi Biomedicine, Wugen, WindMIL Therapeutics, MiNK Therapeutics, CiMaas, Catamaran Bio, Innate Pharma, Healios, Chimeric Therapeutics, ONK Therapeutics, Neukio Biotherapeutics, Exacis Biotherapeutics, Editas Medicine, and others.
• Promising CAR-T Cell Therapy Therapies in the various stages of development include Relmacabtagene autoleucel, KTE-X19, Abecma, Zevorcabtagene autoleucel, Descartes 011, AUTO8, SG299, and others.

Request a sample and discover the recent advances in CAR-T Cell Therapy Drugs @ CAR-T Cell Therapy Competitive Landscape Report- https://www.delveinsight.com/sample-request/cart-cell-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

The CAR-T Cell Therapy report provides an in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing, and acquisition - deal values trends. The sub-segmentation is described in the CAR-T Cell Therapy report which provides company-company collaboration (licensing/partnering), company academic collaboration, and acquisition analysis in tabulated form.

CAR-T Cell Therapy Overview
CAR T-cells are the fusion proteins of a selected single-chain fragment variable from a specific monoclonal antibody and one or more T-cell receptor intracellular signaling domains. A CAR combines antigen-binding domains-most commonly, a single-chain variable fragment (scFv) derived from the variable domains of antibodies with the signaling domains of the TCR chain and additional costimulatory domains from receptors, such as CD28, OX40, and CD137.

Find out more about CAR-T Cell Therapy Analytical Perspective: In-depth Commercial Assessment @ CAR-T Cell Therapy Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/cart-cell-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

CAR-T Cell Therapy Companies and Therapies
• CARsgen: Zevorcabtagene autoleucel
• Cartesian Therapeutics: Descartes 011
• Autolus Therapeutics PLC: AUTO8
• Sana Biotechnology: SG299

CAR T- Cell Therapy Competitive Landscape
The CAR-T Cell Therapy competitive landscape report comprises of comparative assessment of Companies (by therapy, development stage, and technology).

CAR T- Cell Therapy Report Assessment
• CAR T-Cell Therapy Company Analysis
• CAR T-Cell Therapy Therapeutic Assessment
• CAR T- Cell Therapy Pipeline Assessment
• CAR T-Cell Therapy Inactive Drugs Assessment
• CAR T-Cell Therapy Unmet Needs

Learn more about the emerging CAR-T Cell Therapy Competitive Landscape @ CAR-T Cell Therapy Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/cart-cell-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the CAR-T Cell Therapy Report
• Coverage- Global
• CAR-T Cell Therapy Therapeutics Assessment: Product Type, Stage and Product Type, Route of Administration, Molecule Type
• CAR-T Cell Therapy Companies- Cartesian Therapeutics, CASI Pharmaceuticals, Juventas Cell Therapy, Novartis, Poseida Therapeutics, Shanghai Unicar-Therapy Bio-medicine Technology, JW Therapeutics, Gilead Sciences, Cellular Biomedicine Group, Gracell Bio, Mustang Bio, Servier, iCell Gene Therapeutics, Kecellitics Biotech Company Ltd, Gilead sciences, Miltenyi Biotech, Nanjing KAEDI Biotech, Liminatus Pharma, Yake Biotechnology, AffyImmune Therapeutics, Fundamenta Therapeutics, Actinium Pharmaceuticals, Allogene Therapeutics, Celyad Oncology, Maxcyte, Sorrento Therapeutics, Cellular Biomedicine Group, Sorrento Therapeutics, Shanghai GeneChem Co., Ltd., Sensei Biotherapeutics, Obsidian Therapeutics, Beijing Biohealthcare Biotechnology Co. Ltd. , Eutilex/Utilities, Precigen, Inc., Miltenyi Biomedicine, Wugen, WindMIL Therapeutics, MiNK Therapeutics, CiMaas, Catamaran Bio, Innate Pharma, Healios, Chimeric Therapeutics, ONK Therapeutics, Neukio Biotherapeutics, Exacis Biotherapeutics, Editas Medicine, and others.
• CAR-T Cell Therapy Therapies- Relmacabtagene autoleucel, KTE-X19, Abecma, Zevorcabtagene autoleucel, Descartes 011, AUTO8, SG299, and others.

Dive deep into rich insights for new drugs for CAR-T Cell Therapy Product Developmental Activities, Visit @ CAR-T Cell Therapy Research and Development Activities- https://www.delveinsight.com/sample-request/cart-cell-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. CAR T - Cell Therapy: Overview
4. CAR T - Cell Therapy-Analytical Perspective: In-depth Commercial Assessment
5. Competitive Landscape
6. Therapeutic Assessment
7. CAR T - Cell Therapy: Company and Product Profiles (Marketed Therapies)
8. JW Therapeutics
9. Relmacabtagene autoleucel
10. Oncolytic Virus Cancer Therapy: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Registered)
12. CARsgen
13. Zevorcabtagene autoleucel
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. Cartesian Therapeutics
17. Descartes 011
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Autolus Therapeutics
21. AUTO-8
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Sana Biotechnology
25. SG299
26. Drug profiles in the detailed report…..
27. Inactive Products
28. CAR T - Cell Therapy - Unmet needs
29. CAR T - Cell Therapy- Market drivers and barriers
30. Appendix

For further information on the CAR-T Cell Therapy Report @ CAR-T Cell Therapy Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/cart-cell-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

List of Top Selling Market Research Reports in 2024

stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
pigment epithelial detachment market- https://www.delveinsight.com/report-store/pigment-epithelial-detachment-market
Neuroendocrine Tumor Market- https://www.delveinsight.com/report-store/neuroendocrine-tumors-net-market
medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
indwelling catheters market- https://www.delveinsight.com/report-store/indwelling-catheters-market
keloid market- https://www.delveinsight.com/report-store/keloid-market
mouth neoplasms market- https://www.delveinsight.com/report-store/mouth-neoplasms-market
urinary retention market- https://www.delveinsight.com/report-store/urinary-retention-market
sglt2 inhibitors market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
urea cycle disorders market- https://www.delveinsight.com/report-store/urea-cycle-disorders-market
intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
vascular grafts market- https://www.delveinsight.com/report-store/vascular-grafts-market
embolotherapy market- https://www.delveinsight.com/report-store/embolotherapy-market
skin neoplasm market- https://www.delveinsight.com/report-store/skin-neoplasms-market
pelvic organ prolapse market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
thrombectomy devices market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
varicose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
bone growth stimulators market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
brucellosis market- https://www.delveinsight.com/report-store/brucellosis-market
meningococcal meningitis market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
wound healing devices market- https://www.delveinsight.com/report-store/wound-healing-devices-market
cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
endoscopic ultrasound market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
wilms tumor market- https://www.delveinsight.com/report-store/wilms-tumor-market
Rhabdomyosarcoma market- https://www.delveinsight.com/report-store/rhabdomyosarcoma-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CAR-T Cell Therapy Competitive Landscape 2024 (Updated) here

News-ID: 3711023 • Views:

More Releases from DelveInsight

Spinal Implants Market Size Report 2032: Market Porter's Five Forces Analysis, Market Access, Market Drivers & Barriers, Market Restraints and Market Opportunities
Spinal Implants Market Size Report 2032: Market Porter's Five Forces Analysis, M …
DelveInsight's Spinal Implants Market Insights Report 2032 provides the current and forecast market analysis, individual leading Spinal Implants Companies market shares, challenges, Spinal Implants Market Drivers, barriers, trends, and key market Spinal Implants companies in the market. To read more about the latest highlights related to the Spinal Implants Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Spinal
Genome Editing Market Size Report 2032: Market Porter's Five Forces Analysis, Market Accessment, Market Drivers & Barriers, Market Restraints and Market Opportunities
Genome Editing Market Size Report 2032: Market Porter's Five Forces Analysis, Ma …
DelveInsight's Genome Editing Market Insights Report 2032 provides the current and forecast market analysis, individual leading Genome Editing Companies market shares, challenges, Genome Editing Market Drivers, barriers, trends, and key market Genome Editing companies in the market. To read more about the latest highlights related to the Genome Editing Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/genome-editing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Genome Editing Market
Retinopathy of Prematurity Therapeutics Market: Early-Stage Pipeline and FDA Designations Signal Innovation Momentum, finds DelveInsight | Novartis, Regeneron, Bayer, FeliQS Corporation, Infant Bacterial Therapeutics
Retinopathy of Prematurity Therapeutics Market: Early-Stage Pipeline and FDA Des …
The Retinopathy of Prematurity treatment market is expected to witness significant growth in the coming years, primarily driven by advancements in diagnostic technologies and the development of novel therapeutics by key players such as Novartis, Regeneron, Bayer, FeliQS Corporation, and Infant Bacterial Therapeutics, among others. This growth trajectory is further supported by the rising awareness about Retinopathy of Prematurity management, improvements in neonatal care units, and increasing focus on preventive
Chronic Kidney Disease Market Evolution: Novel Drugs, AI Integration, and Combination Therapies Expand Treatment Horizons, finds DelveInsight | AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Vifor Pharma, Otsuka Pharmaceutical, Reata Pharmaceuticals
Chronic Kidney Disease Market Evolution: Novel Drugs, AI Integration, and Combin …
The chronic kidney disease (CKD) treatment market is witnessing robust expansion across the 7MM. This upward trajectory is primarily fueled by increasing disease prevalence, growing aging populations, rising diabetes and hypertension cases, and the emergence of innovative therapies from key chronic kidney disease players including AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Vifor Pharma, Otsuka Pharmaceutical, Reata Pharmaceuticals, Akebia Therapeutics, and Kyowa Kirin, among others, who are actively advancing the CKD

All 5 Releases


More Releases for Cell

Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting. Download Full PDF Sample Copy
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging